The heterogeneous but co-existing distribution of these EGFR, MET, and PDGFRA gene amplifications suggests that glioblastoma may undergo a dynamic evolution during tumour progression that creates diversity within a single mass [13]. The gene discussed is MET; the disease is neoplasm.